Qvgmysjiqamyqidb2pvm cellesce


No Reviews Yet
No Completed Orders
Cardiff, GB

About Cellesce

Founded: 2013

Cellesce was founded in 2013 and is built on biochemical and bioprocess engineering expertise from the University of Bath and cell and organoid biology expertise from Cardiff University. In December 2017 Cellesce moved into the Medicentre in Cardiff, Wales.

Cellesce is a Biotech company that has developed a new patented bioprocessing technology for the growing and expansion of organoids. Organoids are a 3D cell structures with organ-like characteristics grown from stem cells. The Company is currently commercialising organoid models that are a powerful new enabling technology in drug discovery and genetics research.

Our Services (1)



Price on request

Cellesce has initially focused on providing expansion services for colorectal cancer and other organoids. These colorectal cancer organoids reflect the genetic diversity found in the major colorectal cancer sub-types. Full exome sequencing, mutational analysis and pharmacology data are provided for each organoid to demonstrate their relevance to tumour pathology. These can now be made available in commercial quantities required for compound screening in drug discovery or large-scale genetics research, as required. For example, we can provide expansion services for organoids derived from our biobank partners.

  • Organoids shipped in frozen cryovials, ready for seeding into assay format. Each vial contains enough organoids for c.500 data points*
  • Organoids derived from patient tissue from a range of colorectal sites and selected by the TNM classification of malignant tumours
  • Organoids analysed for key driver mutations, using the SureSeq™ Solid Tumour Panel from Oxford Gene Technology (OGT), including but not limited to: APC, BRAF, EGFR, HRAS, KRAS, PDGFR, PIK3CA, PTEN, TP53, VHL mutations, as well as whole exome sequencing
  • In-house characterisation against a number of known colorectal cancer targeting pharmacological agents to demonstrate their relevance to drug discovery
  • Varied morphologies and growth profiles

*Based on assays performed in 96 or 384 well format

Custom expansion services

  • Expansion of your own organoid lines or line derivation from PDX tissue
  • Using your current protocols, Cellesce will work to determine optimum condiditons for expansion in our systems, before expanding and supplying back to you in your desired quantities

Coming soon

  • Wild type ‘normal’ colorectal lines, prostate, breast and organoids of other tissue types from our biobank partners
  • We are also developing larger scale bioreactor systems to enable provision of significantly larger scale organoids with minimal batch-to-batch variation

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.

Hozefa Amijee

Business Development Executive

Victoria Marsh Durban

Chief Operating Officer

Cellesce has not received any reviews.

Cellesce has not received any endorsements.